-
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
Pandya PP, Snijders RJ, Johnson SP, Brizot ML, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:957-62. -
Neutrophil and monocyte beta 2-integrin expression in trisomic fetuses.
Makrydimas G, Thilaganathan B, Plachouras N, Nicolaides KH.
Prenat Diagn 1995;15:325-7. -
Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks' gestation.
Kuhn P, Brizot ML, Pandya PP, Snijders RJ, Nicolaides KH.
Am J Obstet Gynecol 1995;172:32-5. -
Morphometric analysis of the great vessels in early fetal life.
Hyett JA, Moscoso G, Nicolaides KH.
Hum Reprod 1995;10:3045-8. -
Maternal serum Schwangerschafts protein-1 (SP1) and fetal chromosomal abnormalities at 10-13 weeks' gestation.
Brizot ML, Bersinger NA, Xydias G, Snijders RJ, Nicolaides KH.
Early Hum Dev 1995;43:31-6. -
First trimester maternal serum alpha-fetoprotein in fetal trisomies.
Brizot ML, Khun P, Bersinger NA, Snijders RJM, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:31-4. -
Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
Brizot ML, Snijders RJ, Butler J, Bersinger NA, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:127-32. -
Fetal and maternal hCG concentration in aneuploid pregnancies.
Abbas A, Chard T, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:561-3.